BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin
BARDA partners with Mapp Biopharmaceutical, Inc. to develop next generation therapeutic for Botulinum Neurotoxin BARDA...
MappBio Announces Contract with BARDA for MBP091 as a pan-Marburg Medical Countermeasure
MappBio Announces Contract with BARDA for MBP091 as a pan-Marburg Medical...
Experimental antibody ‘cocktail’ protects animals from three deadly Ebola viruses
Public Release
MappBio Announces Contract with BARDA for Sudan Ebolavirus Medical Countermeasure
MappBio Announces Contract with BARDA for Sudan Ebolavirus Medical Countermeasure September 28, 2018 – (SAN DIEGO,...